No Data
Express News | Nurix Therapeutics : Anticipate Sharing Additional Clinical Data About Ongoing Phase 1B Expansion Cohort in 2025
Nurix Therapeutics Receives U.S. FDA Fast Track Designation for NX-5948 for the Treatment of Relapsed or Refractory Waldenstrom's Macroglobulinemia
Express News | Nurix Therapeutics Receives U.S. FDA Fast Track Designation for Nx-5948 for the Treatment of Relapsed or Refractory Waldenstrom’s Macroglobulinemia
Is Nurix Therapeutics (NRIX) the Worst ARK Stock to Buy According to Short Sellers?
A Quick Look at Today's Ratings for Nurix Therapeutics(NRIX.US), With a Forecast Between $29 to $35
Nurix Therapeutics Is Maintained at Buy by HC Wainwright & Co.
No Data
Iwill TradeScared : Already 500% current year where is yearly bottom of strong buy potential
Iwill TradeScared : Time to make separate watchlist of strong buys so get better cost price for less red days